Rebecca Hubbard, Ph.D.

Professor
1Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania
Philadelphia, Pennsylvania, United States

Johnson & Johnson (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Merck (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Pfizer (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)

Presentation(s):

• Arterial and Venous Thrombotic Events in Patients with COVID-19 Compared to Influenza

  Saturday, August 27, 2022
  1:15 PM – 1:30 PM CEST

• Association Between Very High PD-L1 Expression versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-small Cell Lung Cancer

  Sunday, August 28, 2022
  9:30 AM – 9:45 AM CEST